Mark Stanley Berger - 30 Jun 2025 Form 4 Insider Report for Genprex, Inc. (GNPX)

Role
Chief Medical Officer
Signature
/s/ Mark Berger
Issuer symbol
GNPX
Transactions as of
30 Jun 2025
Net transactions value
-$1,026
Form type
4
Filing time
01 Jul 2025, 17:52:13 UTC
Previous filing
19 Feb 2025
Next filing
23 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Berger Mark Stanley Chief Medical Officer 3300 BEE CAVE ROAD, #650-227, AUSTIN /s/ Mark Berger 01 Jul 2025 0001700283

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNPX Common Stock Tax liability $1,026 -4,500 -20% $0.2279 17,971 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld on June 30, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.